共 16 条
[1]
GENETIC-DIFFERENCES IN PHENYTOIN PHARMACOKINETICS - INVIVO CLEARANCE AND INVITRO METABOLISM AMONG INBRED STRAINS OF MICE
[J].
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS,
1980, 1 (05)
:281-304
[2]
SINGLE AND MULTIPLE ION RECORDING TECHNIQUES FOR ANALYSIS OF DIPHENYLHYDANTOIN AND ITS MAJOR METABOLITE IN PLASMA
[J].
BIOMEDICAL MASS SPECTROMETRY,
1977, 4 (01)
:36-41
[3]
BLAKE DA, 1978, DRUG METAB DISPOS, V6, P240
[4]
CHANG T, 1982, ANTIEPILEPTIC DRUGS, P209
[5]
DAM M, 1982, ANTIEPILEPTIC DRUGS, P247
[6]
SIMULTANEOUS DETERMINATION OF PHENYTOIN, PHENOBARBITAL AND THEIR PARA-HYDROXYLATED METABOLITES IN URINE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
[J].
JOURNAL OF CHROMATOGRAPHY,
1979, 162 (01)
:104-109
[7]
ASSAY OF MAJOR (4-HYDROXYLATED) METABOLITE OF DIPHENYLHYDANTOIN IN HUMAN URINE BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
[J].
JOURNAL OF CHROMATOGRAPHY,
1977, 130 (JAN11)
:422-425
[8]
MASS FRAGMENTOGRAPHIC DETERMINATION OF DIPHENYLHYDANTOIN AND ITS MAIN METABOLITE, 5-(4-HYDROXYPHENYL)-5-PHENYLHYDANTOIN, IN HUMAN PLASMA
[J].
JOURNAL OF CHROMATOGRAPHY,
1976, 116 (01)
:53-61
[9]
KUTT H, 1971, J PHARMACOL EXP THER, V176, P11
[10]
KUTT H, 1982, ANTIEPILEPTIC DRUGS, P227